Contribute Try STAT+ Today

A biotechnology company that is trying to create CRISPR-edited pigs so their organs could be safely transplanted into people has produced animals with a record number of genetic changes, the startup’s chief scientific officer and her colleagues reported on Thursday.

The eGenesis scientists had previously used CRISPR-Cas9 genome editing to remove 25 potentially dangerous-to-humans viruses from pigs’ genome. In the new paper, CSO Luhan Yang and her teams at both eGenesis and Qihan Bio, another xenotransplantation company she co-founded, surpassed that milestone, creating cloned pigs with additional genetic changes. She calls them Pig3.0.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.